No writing assistance was utilized in the production of this manuscript. Nonalcoholic fatty liver disease (NAFLD) and its more severe form NASH are common liver diseases in industrialized countries.

At the moment, there is a lack of clinically relevant preclinical models for fatty liver disease. This problem has led to most drug candidates that were successful in preclinical development ...

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

In fact, overdoing it can cause one of the two main forms of fatty liver disease, a health-sapping condition that impacts ...

Rezdiffra can be helpful for those who meet the qualifications. Some insurance plans will partially cover the fatty liver disease drug, but there may still be significant out-of-pocket costs—and ...